Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I Van-Praagh
High-Dose BCNU Followed by Autologous Hematopoietic Stem Cell Transplantation in Supratentorial High-Grade Malignant Gliomas: A Retrospective Analysis of 114 Patients
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Brazilian Experience Using High-Dose Sequential Therapy (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Malignant Lymphomas
Revista Brasileira de Hematologia e Hemoterapia
Dose-Intense BCNU/Melphalan Regimen Followed by Autologous Hematopoietic Cell Transplantation (AHCT) Results in Prolonged PFS in Myeloma Patients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Malignant Lymphoproliferative Disorders
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
High Dose Chemotherapy (HDT) With Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (Pts) With High Risk Solid Tumors
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Is High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation in Breast Cancer Patients a Done Deal?
Women's Health
Medicine
High Dose BCNU Chemotherapy With Autologous Bone Marrow Transplantation and Full Dose Radiotherapy for Grade IV Astrocytoma
British Journal of Cancer
Cancer Research
Oncology
Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
